Objectives (Educational Content) :
1. Recognize that a significant percentage of individuals with cerebral palsy may have a genetic diagnosis. 2. Understand the role of genetic testing in the evaluation of individuals with cerebral palsy. 3. Identify a need for improving access to genetic testing for CP and related neurodevelopmental disorders.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Many clinicians are unaware of the genetic underpinnings of cerebral palsy and related neurodevelopmental disorders, leading to underutilization of genetic testing and missed opportunities for diagnosis, counseling, and targeted care.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
07-10-2026
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
The following presenters have identified that they have no financial relationships with any ineligible companies. Siddharth Srivastava, MD The following planning committee member has indicated that a financial relationship with an ineligible company: Merk Maria Victorio, MD All relationships have been mitigated. The remaining planning committee/CME committee members have indicated that they have no financial relationships with any ineligible companies.
Accreditation Statement:
Akron Children’s Hospital is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
Akron Children’s Hospital designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
1. Srivastava et al., Ann Neurol . 2024 Nov;96(5):900-913. [39319594]
2. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisama FM; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Nov;23(11):2029-2037. doi: 10.1038/s41436-021-01242-6. Epub 2021 Jul 1. PMID: 34211152.
3. Srivastava et al., Genet Med. 2019 Nov;21(11): 2413-2421 [31182824]
